This inventor holds 1 USPTO granted patent. Top assignee: Teijin Limited. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Teruhisa Noguchi: Innovator in Antitumor Protein Research
Introduction
Teruhisa Noguchi is a prominent inventor based in Fujisawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antitumor proteins. His innovative work has led to the creation of a unique hybrid protein that holds promise for cancer treatment.
Latest Patents
Teruhisa Noguchi holds a patent for an antitumor protein hybrid and the process for its preparation. This hybrid is composed of a moiety that is substantially the fragment Fab of an antitumor immunoglobulin and a moiety that is substantially the fragment A of a diphtheria toxin. The patent is a testament to his expertise and dedication to advancing medical science.
Career Highlights
Throughout his career, Teruhisa Noguchi has been associated with Teijin Limited, a company known for its commitment to innovation in various fields, including healthcare. His work at Teijin has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Yasuhiko Masuho and Takeshi Hara. Their collaboration has fostered an environment of creativity and innovation, leading to advancements in the field of antitumor research.
Conclusion
Teruhisa Noguchi's contributions to the field of biotechnology, particularly through his patent on antitumor protein hybrids, highlight his role as an influential inventor. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile